Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update
Go back to Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $0.01 | |||
| Open | $0.25 | 52 Week Low | $0.00 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $-0.02 | |||
| Volume | 779,526 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.88 -0.42 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.30 | 52 Week High | $117.12 | |||
| Open | $15.10 | 52 Week Low | $46.52 | |||
| Day High | $15.25 | P/E | N/A | |||
| Day Low | $14.63 | EPS | $-1.97 | |||
| Volume | 5,921,192 | |||||
